Pharma Deals

Merger and Acquisition Transactions in Pharma, Licensing Deals,

Pages

  • Home
  • Global Pharma Intelligence
  • Japan Pharma Intelligence
  • Clinical Trial Data
  • Health News
  • Investment Ideas
  • New Drug Approvals
No posts with label HER2+VE BREAST CANCER. Show all posts
No posts with label HER2+VE BREAST CANCER. Show all posts
Home
Subscribe to: Posts (Atom)

Search Pharma Deals

My Headlines

Subscribe to Pharma Deals by Email

Global Pharmaceutical Market Intelligence

Loading...

Popular Posts

  • Otsuka to acquire Astex Pharmaceuticals for $886m
  • Hikma to acquire Egyptian company for Pharmaceuticals and Chemicals Industries (EPCI)
  • Azaya therapeutics outlicenses rights to liposomal docetaxel (AT1123) to Beijing’s CANbridge Lifescience
  • Servier in licensing pact with SIMM for the development in China of lucitanib
  • AstraZeneca and Merck & Co Inc enter into worldwide licensing agreement for Merck's oral small molecule inhibitor of WEE1 kinase (MK-1775)
  • Eddingpharm inlicenses China rights to Entinostat from Syndax Pharma
  • Valeant to acquire dermatology company Obagi Medical Products for $310m net of cash
  • Merz acquires cosmetics and over the counter and prescription skin care business of switzerland based dermatology company Neocutis
  • Lee Pharma buys China Rights for Kalbitor (ecallantide - for treatment of Hereditary Angioedema) from Dyax
  • Vivimed Acquires Finoso Pharma for $2.8M

Subscribe via email

Enter your email address:

Delivered by FeedBurner

Archive

Ethereal theme. Powered by Blogger.